G Aus1, J Hugosson, L Norlén. 1. Department of Urology, Göteborg University, Ostra Hospital, Sweden.
Abstract
PURPOSE: We investigate the ultimate need for palliative treatments and hospital care in prostate cancer patients treated with noncurative intent. MATERIALS AND METHODS: A retrospective analysis was done of 514 prostate cancer patients who died between 1988 and 1990. RESULTS: Of the patients who later died of prostate cancer 61% needed 1 or more palliative treatments (transurethral resection of the prostate, radiation treatment or upper urinary tract diversion) before death. An average of 5 weeks was spent in the hospital due to prostate cancer. CONCLUSIONS: Patients who failed deferred treatment (thus dying of prostate cancer) needed a considerable amount of hospital care and palliative therapy before they ultimately died of the disease.
PURPOSE: We investigate the ultimate need for palliative treatments and hospital care in prostate cancerpatients treated with noncurative intent. MATERIALS AND METHODS: A retrospective analysis was done of 514 prostate cancerpatients who died between 1988 and 1990. RESULTS: Of the patients who later died of prostate cancer 61% needed 1 or more palliative treatments (transurethral resection of the prostate, radiation treatment or upper urinary tract diversion) before death. An average of 5 weeks was spent in the hospital due to prostate cancer. CONCLUSIONS:Patients who failed deferred treatment (thus dying of prostate cancer) needed a considerable amount of hospital care and palliative therapy before they ultimately died of the disease.
Authors: S A Grover; L Coupal; H Zowall; R Rajan; J Trachtenberg; M Elhilali; M Chetner; L Goldenberg Journal: CMAJ Date: 2000-04-04 Impact factor: 8.262
Authors: Ana M Aparicio; Andrea L Harzstark; Paul G Corn; Sijin Wen; John C Araujo; Shi-Ming Tu; Lance C Pagliaro; Jeri Kim; Randall E Millikan; Charles Ryan; Nizar M Tannir; Amado J Zurita; Paul Mathew; Wadih Arap; Patricia Troncoso; Peter F Thall; Christopher J Logothetis Journal: Clin Cancer Res Date: 2013-05-06 Impact factor: 12.531
Authors: Kara Babaian; Matthew Truong; Jeremy Cetnar; Deanna S Cross; Fangfang Shi; Mark A Ritter; David F Jarrard Journal: BJU Int Date: 2012-11-06 Impact factor: 5.588
Authors: James A Eastham; Michael W Kattan; Paul Fearn; Gabrielle Fisher; Daniel M Berney; Tim Oliver; Christopher S Foster; Henrik Møller; Victor Reuter; Jack Cuzick; Peter Scardino Journal: Eur Urol Date: 2007-05-30 Impact factor: 20.096